Tag : advanced

Latest News

Updated CheckMate -025 Results Show 26% of Patients Treated with Opdivo are Alive at Five Years in Patients with Previously Treated Advanced or Metastatic Renal Cell Carcinoma

Newsemia
PRINCETON, N.J.–(BUSINESS WIRE)—- $BMY #BMS–Updated CheckMate -025 Results Show 26% of Patients Treated with Opdivo are Alive at Five Years in Patients with Previously Treated...
Latest News

Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Continued Survival Benefit at 42-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Newsemia
PRINCETON, N.J.–(BUSINESS WIRE)—- $BMY #BMS–Opdivo Plus Yervoy Demonstrates Continued Survival Benefit at 42-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic RCC Source link...
Latest News

Real-World Study of 6,000+ Medicare Patients with Advanced Prostate Cancer Shows Adding PROVENGE® (sipuleucel-T) to Treatment Regimen Reduced Risk of Death by 45%

Newsemia
SEAL BEACH, Calif.–(BUSINESS WIRE)– #gu20–New study of 6,000+ Medicare patients with advanced prostate cancer shows adding PROVENGE (sipuleucel-T) to treatment reduced risk of death by...
Latest News

Advanced X-ray combination technique aids tuberculosis and osteoporosis research

Newsemia
With an advanced X-ray combination technique, scientists have traced nanocarriers for tuberculosis drugs within cells with very high precision. Source link...
Pharma / Biotech

Safety, Clinical Activity and Pharmacokinetics of Alflutinib (AST2818) in Advanced NSCLC Patients with EGFR T790M Mutation.

Newsemia
Related Articles Safety, Clinical Activity and Pharmacokinetics of Alflutinib (AST2818) in Advanced NSCLC Patients with EGFR T790M Mutation. J Thorac Oncol. 2020 Jan 30;: Authors:...
Pharma / Biotech

A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours.

Newsemia
Related Articles A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours. Cancer Chemother Pharmacol. 2020 Feb 01;:...
Latest News

Global Advanced Power Solutions for Implantable and Wearable Medical Devices Market to Reach $1.77 Billion by 2029 – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Global Advanced Power Solutions for Implantable and Wearable Medical Devices Market: Focus on Power Source, Application, Battery Type, Regional Analysis, Data – Analysis...
Latest News

NantHealth’s Eviti Connect Data Shows Recycling of Chemotherapy and Biologics for Advanced CRC Patients More Common Than Switching to Drug Regimens with Alternative Mechanism of Action

Newsemia
SAN FRANCISCO–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced new real-world data on treatment patterns for patients with advanced colorectal...
Biology

Complex Reconstructive Procedures are Offered at The Institute for Advanced Reconstruction at The Plastic Surgery Center Courtesy of a Few NJ Top Docs

Newsemia
SCOTCH PLAINS, N.J. (PRWEB) January 24, 2020 The plastic and reconstructive surgeons at The Institute for Advanced Reconstruction (IFAR) at The Plastic Surgery Center in...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy